脳血栓除去デバイス市場、規模、シェア、動向、産業分析レポート：製品別、最終用途別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、脳血栓除去デバイス市場規模は2034年までに14億1,833万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

脳血栓除去デバイス市場は、急性虚血性脳卒中を患う患者の脳から血栓を除去し、血流を回復させて神経学的合併症を予防するために設計された医療器具に焦点を当てています。同市場は、世界の脳卒中発症率の上昇、低侵襲手技の採用増加、血栓回収・吸引装置の継続的な技術進歩により、大きな成長を遂げています。脳血栓除去デバイスの市場機会は、ヘルスケアインフラと意識の向上が高度な脳卒中治療への需要を促進している新興国市場で生まれています。主な動向としては、脳卒中診断のための人工知能の統合、製品革新のための臨床研究の拡大、先進国市場における償還支援の拡大などが挙げられます。規制当局の承認や市場関係者間の戦略的提携の増加により、脳血栓除去デバイス市場は今後数年でさらに拡大すると予想されます。

脳血栓除去デバイス市場レポートハイライト

製品別では、血栓回収装置が機械的血栓除去術における高い有効性により、2024年の脳血栓除去デバイス市場の収益で最大のシェアを占めました。一方、吸引/吸引装置は真空アシスト血栓除去技術の進歩により、最も高い成長が見込まれています。

一方、外来手術センターは、低侵襲手技と患者の早期回復に対する需要の増加により急成長を遂げています。

北米は、高度なヘルスケアインフラ、脳卒中発症率の高さ、強力な償還政策により最大の市場シェアを占めており、アジア太平洋は、医療投資の増加、認知度の向上、脳卒中管理施設の改善により、最も急速に成長している地域です。

市場の主要企業としては、Abbott Laboratories、Acandis GmbH、AngioDynamics, Inc.、Argon Medical Devices, Inc.、Boston Scientific Corporation、Edwards Lifesciences Corporation、Johnson &Johnson Services, Inc.（Cerenovus）、LeMaitre Vascular, Inc.、Medtronic plc、MicroVention, Inc.（テルモの子会社）、Penumbra, Inc.、Phenox GmbH、Stryker Corporation、Terumo Corporation、Vesalio, LLCなどが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の脳血栓除去デバイス市場の洞察

• 市場スナップショット
• 脳血栓除去デバイス市場力学
  • 促進要因と機会
    • 虚血性脳卒中の発生率の上昇
    • 機械的血栓除去術の進歩
  • 抑制要因と課題
    • 手続きコストが高め
• PESTEL分析
• 脳血栓除去デバイス市場動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界の脳血栓除去デバイス市場：製品別

• 主な調査結果
• イントロダクション
• クロット・レトリーバー
• 吸引装置
• 血管スネア

第6章 世界の脳血栓除去デバイス市場：最終用途別

• 主な調査結果
• イントロダクション
• 病院
• 救急クリニック
• 外来手術センター

第7章 世界の脳血栓除去デバイス市場：地域別

• 主な調査結果
• イントロダクション
  • 脳血栓除去デバイス市場評価：地域別、2020～2034年
• 北米
  • 北米：製品別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：製品別、2020～2034年
  • 欧州：用途別、最終2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：製品別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：製品別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：製品別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第8章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第9章 企業プロファイル

• Abbott Laboratories
• Acandis GmbH
• AngioDynamics, Inc.
• Argon Medical Devices, Inc.
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Johnson & Johnson Services, Inc.（Cerenovus）
• LeMaitre Vascular, Inc.
• Medtronic plc
• MicroVention, Inc.（a subsidiary of Terumo Corporation）

List of Tables:

• Table 1 Global Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 2 Global Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 3 North America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 4 North America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 5 U.S.: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 6 U.S.: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 7 Canada: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 8 Canada: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 9 Europe: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 10 Europe: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 11 UK: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 12 UK: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 13 France: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 14 France: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 15 Germany: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 16 Germany: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 17 Italy: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 18 Italy: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 19 Spain: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 20 Spain: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 21 Netherlands: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 22 Netherlands: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 23 Russia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 24 Russia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 25 Rest of Europe: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 26 Rest of Europe: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 27 Asia Pacific: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 28 Asia Pacific: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 29 China: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 30 China: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 31 India: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 32 India: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 33 Malaysia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 34 Malaysia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 35 Japan: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 36 Japan: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 37 Indonesia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 38 Indonesia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 39 South Korea: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 40 South Korea: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 41 Australia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 42 Australia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 43 Rest of Asia Pacific: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 44 Rest of Asia Pacific: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 45 Middle East & Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 46 Middle East & Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 47 Saudi Arabia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 48 Saudi Arabia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 49 UAE: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 50 UAE: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 51 Israel: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 52 Israel: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 53 South Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 54 South Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 55 Rest of Middle East & Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 56 Rest of Middle East & Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 57 Latin America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 58 Latin America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 59 Mexico: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 60 Mexico: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 61 Brazil: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 62 Brazil: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 63 Argentina: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 64 Argentina: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• Table 65 Rest of Latin America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• Table 66 Rest of Latin America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)

List of Figures:

• Figure 1. Global Neurothrombectomy Devices Market, 2020-2034 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Product
• Figure 7. Global Neurothrombectomy Devices Market, by Product, 2024 & 2034 (USD Million)
• Figure 8. Market by End-Use
• Figure 9. Global Neurothrombectomy Devices Market, by End-Use, 2024 & 2034 (USD Million)

The neurothrombectomy devices market size is expected to reach USD 1,418.33 million by 2034, according to a new study by Polaris Market Research. The report "Neurothrombectomy Devices Market Size, Share, Trends, Industry Analysis Report: By Product (Clot Retrievers, Aspiration/Suction Devices, and Vascular Snares), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neurothrombectomy devices market focuses on medical instruments designed to remove blood clots from the brain in patients suffering from acute ischemic stroke, helping restore blood flow and prevent neurological complications. The market is experiencing significant growth due to the rising incidence of stroke globally, increasing adoption of minimally invasive procedures, and continuous technological advancements in clot retrieval and aspiration devices. Neurothrombectomy devices market opportunities are emerging in developing regions where improving healthcare infrastructure and awareness are driving demand for advanced stroke treatments. Key trends include the integration of artificial intelligence for stroke diagnosis, expanding clinical research for product innovation, and growing reimbursement support in developed markets. With increasing regulatory approvals and strategic collaborations among market players, the neurothrombectomy devices market is expected to expand further in the coming years.

Neurothrombectomy Devices Market Report Highlights

By product, the clot retrievers segment accounted for the largest share of the neurothrombectomy devices market revenue in 2024 due to their high efficacy in mechanical thrombectomy procedures, while aspiration/suction devices are expected to witness the highest growth due to advancements in vacuum-assisted clot removal technologies.

By end use, the hospitals segment dominated the neurothrombectomy devices market share as they are the primary centers for stroke treatment with well-equipped neurovascular units, while ambulatory surgical centers are experiencing rapid growth due to increasing demand for minimally invasive procedures and faster patient recovery.

North America holds the largest market share due to advanced healthcare infrastructure, high stroke incidence, and strong reimbursement policies, while Asia-Pacific is the fastest-growing region driven by rising healthcare investments, increasing awareness, and improving stroke management facilities.

A few major companies in the market are Abbott Laboratories; Acandis GmbH; AngioDynamics, Inc.; Argon Medical Devices, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Johnson & Johnson Services, Inc. (Cerenovus); LeMaitre Vascular, Inc.; Medtronic plc; MicroVention, Inc. (a subsidiary of Terumo Corporation); Penumbra, Inc.; Phenox GmbH; Stryker Corporation; Terumo Corporation; and Vesalio, LLC.

Polaris Market Research has segmented the neurothrombectomy devices market report on the basis of product, end use, and region:

By Product Outlook (Revenue - USD Million, 2020-2034)

Clot Retrievers

Aspiration/Suction Devices

Vascular Snares

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals

Emergency Clinics

Ambulatory Surgical Centers

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Neurothrombectomy Devices Market Insights

• 4.1. Neurothrombectomy Devices Market - Market Snapshot
• 4.2. Neurothrombectomy Devices Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Incidence of Ischemic Strokes
    • 4.2.1.2. Advancements in Mechanical Thrombectomy Procedures
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High procedural costs
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Neurothrombectomy Devices Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Neurothrombectomy Devices Market, by Product

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• 5.3. Clot Retrievers
  • 5.3.1. Global Neurothrombectomy Devices Market, by Clot Retrievers, by Region, 2020-2034 (USD Million)
• 5.4. Aspiration/Suction Devices
  • 5.4.1. Global Neurothrombectomy Devices Market, by Aspiration/Suction Devices, by Region, 2020-2034 (USD Million)
• 5.5. Vascular Snares
  • 5.5.1. Global Neurothrombectomy Devices Market, by Vascular Snares, by Region, 2020-2034 (USD Million)

6. Global Neurothrombectomy Devices Market, by End-Use

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 6.3. Hospitals
  • 6.3.1. Global Neurothrombectomy Devices Market, by Hospitals, by Region, 2020-2034 (USD Million)
• 6.4. Emergency Clinics
  • 6.4.1. Global Neurothrombectomy Devices Market, by Emergency Clinics, by Region, 2020-2034 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Global Neurothrombectomy Devices Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Million)

7. Global Neurothrombectomy Devices Market, by Geography

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Neurothrombectomy Devices Market Assessment, By Geography, 2020-2034 (USD Million)
• 7.3. Neurothrombectomy Devices Market - North America
  • 7.3.1. North America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.3.2. North America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.3.3. Neurothrombectomy Devices Market - U.S.
    • 7.3.3.1. U.S.: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.3.3.2. U.S.: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.3.4. Neurothrombectomy Devices Market - Canada
    • 7.3.4.1. Canada: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.3.4.2. Canada: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 7.4. Neurothrombectomy Devices Market - Europe
  • 7.4.1. Europe: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.4.2. Europe: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.3. Neurothrombectomy Devices Market - UK
    • 7.4.3.1. UK: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.3.2. UK: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.4. Neurothrombectomy Devices Market - France
    • 7.4.4.1. France: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.4.2. France: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.5. Neurothrombectomy Devices Market - Germany
    • 7.4.5.1. Germany: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.5.2. Germany: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.6. Neurothrombectomy Devices Market - Italy
    • 7.4.6.1. Italy: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.6.2. Italy: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.7. Neurothrombectomy Devices Market - Spain
    • 7.4.7.1. Spain: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.7.2. Spain: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.8. Neurothrombectomy Devices Market - Netherlands
    • 7.4.8.1. Netherlands: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.8.2. Netherlands: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.9. Neurothrombectomy Devices Market - Russia
    • 7.4.9.1. Russia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.9.2. Russia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.10. Neurothrombectomy Devices Market - Rest of Europe
    • 7.4.10.1. Rest of Europe: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.10.2. Rest of Europe: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 7.5. Neurothrombectomy Devices Market - Asia Pacific
  • 7.5.1. Asia Pacific: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.5.2. Asia Pacific: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.3. Neurothrombectomy Devices Market - China
    • 7.5.3.1. China: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.3.2. China: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.4. Neurothrombectomy Devices Market - India
    • 7.5.4.1. India: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.4.2. India: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.5. Neurothrombectomy Devices Market - Malaysia
    • 7.5.5.1. Malaysia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.5.2. Malaysia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.6. Neurothrombectomy Devices Market - Japan
    • 7.5.6.1. Japan: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.6.2. Japan: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.7. Neurothrombectomy Devices Market - Indonesia
    • 7.5.7.1. Indonesia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.7.2. Indonesia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.8. Neurothrombectomy Devices Market - South Korea
    • 7.5.8.1. South Korea: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.8.2. South Korea: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.9. Neurothrombectomy Devices Market - Australia
    • 7.5.9.1. Australia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.9.2. Australia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.10. Neurothrombectomy Devices Market - Rest of Asia Pacific
    • 7.5.10.1. Rest of Asia Pacific: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.10.2. Rest of Asia Pacific: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 7.6. Neurothrombectomy Devices Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.6.2. Middle East & Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.3. Neurothrombectomy Devices Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.3.2. Saudi Arabia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.4. Neurothrombectomy Devices Market - UAE
    • 7.6.4.1. UAE: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.4.2. UAE: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.5. Neurothrombectomy Devices Market - Israel
    • 7.6.5.1. Israel: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.5.2. Israel: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.6. Neurothrombectomy Devices Market - South Africa
    • 7.6.6.1. South Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.6.2. South Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.7. Neurothrombectomy Devices Market - Rest of Middle East & Africa
    • 7.6.7.1. Rest of Middle East & Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.7.2. Rest of Middle East & Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 7.7. Neurothrombectomy Devices Market - Latin America
  • 7.7.1. Latin America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.7.2. Latin America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.7.3. Neurothrombectomy Devices Market - Mexico
    • 7.7.3.1. Mexico: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.7.3.2. Mexico: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.7.4. Neurothrombectomy Devices Market - Brazil
    • 7.7.4.1. Brazil: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.7.4.2. Brazil: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.7.5. Neurothrombectomy Devices Market - Argentina
    • 7.7.5.1. Argentina: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.7.5.2. Argentina: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.7.6. Neurothrombectomy Devices Market - Rest of Latin America
    • 7.7.6.1. Rest of Latin America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.7.6.2. Rest of Latin America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Abbott Laboratories
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Acandis GmbH
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3. AngioDynamics, Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Argon Medical Devices, Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. Boston Scientific Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. Edwards Lifesciences Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development
• 9.7. Johnson & Johnson Services, Inc. (Cerenovus)
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Development
• 9.8. LeMaitre Vascular, Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Development
• 9.9. Medtronic plc
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Development
• 9.10. MicroVention, Inc. (a subsidiary of Terumo Corporation)
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
  • 9.10.4. Recent Development